VERA Vera Therapeutics, Inc.: institutional ownership and insider trading
236 funds reported holding $3.56B of Vera Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $217M, with 27 new positions and 36 funds selling out; over the last 12 months insiders bought $250K and sold $8.99M on the open market.
VERA revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$109M, EPS -1.52
- Quarter ended Mar 31, 2026: revenue n/a, net income −$121M, EPS -1.69
- Quarter ended Dec 31, 2025: revenue n/a, net income −$91.1M, EPS -1.39
- Quarter ended Sep 30, 2025: revenue n/a, net income −$80.3M, EPS -1.26
Famous investors holding VERA
- Renaissance Technologies (Renaissance Technologies): $12.0M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $12.0M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $4.47M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $3.69M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $3.20M, 0.0% of the portfolio
Largest institutional holders of VERA
- BlackRock, Inc. (BLK) — $247M
- Avoro Capital Advisors LLC — $246M
- VANGUARD GROUP INC — $181M
- STATE STREET CORP (STT, STT-PG) — $178M
- PRICE T ROWE ASSOCIATES INC /MD/ — $172M
- Deep Track Capital, LP — $172M
- DEERFIELD MANAGEMENT COMPANY, L.P. — $168M
- Kynam Capital Management, LP — $124M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $120M
- Sofinnova Investments, Inc. — $120M
Recent VERA insider trades
- Sep 15, 2026: Fordyce Marshall sold 18,500 shares ($685K)
- Sep 2, 2026: Fordyce Marshall sold 18,500 shares ($650K)
- Jul 7, 2026: Fordyce Marshall sold 46,250 shares ($1.96M)
- Jun 23, 2026: Fordyce Marshall sold 18,500 shares ($702K)
5%+ owners
- BlackRock, Inc.: 7.4% (Schedule 13G/A, filed Jul 30, 2026)
- T. Rowe Price Associates, Inc.: 6.4% (Schedule 13G/A, filed May 15, 2026)
- STATE STREET CORPORATION: 5.8% (Schedule 13G, filed Aug 7, 2026)
Who owns the most VERA stock?
The largest institutional holders of Vera Therapeutics, Inc. in the latest 13F filings are BlackRock, Inc. (BLK) ($247M), Avoro Capital Advisors LLC ($246M), VANGUARD GROUP INC ($181M).
Are insiders buying or selling VERA?
Over the last 12 months insiders bought $250K and sold $8.99M of Vera Therapeutics, Inc. stock on the open market (SEC Form 4).
Which famous investors own VERA?
Renaissance Technologies, Izzy Englander, Two Sigma, Ken Griffin, D. E. Shaw.
Which ETFs hold VERA?
21 ETFs and mutual funds hold it among their top 100 positions, including XBI, PRHSX, IBB, QUACX.